Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Immunohematology market industry 3600 synopsis, 2016 - 2027
2.1.1 Business trends
2.1.2 Technology trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 Immunohematology Market Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 - 2027
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing number of blood banks and trauma centres in developed countries
3.3.1.2 Rising prevalence rate of various hematological disorders
3.3.1.3 Increasing number of blood donation awareness programs in developing countries
3.3.1.4 Technological advancements in immunohematology
3.3.2 Industry pitfalls & challenges
3.3.2.1 Dearth of skilled professionals
3.3.2.2 Stringent regulatory policies
3.3.2.3 High costs of techniques
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By technology
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Market entry landscape
3.7 Regulatory landscape
3.8 Porter's analysis
3.9 Competitive landscape, 2020
3.9.1 Company matrix analysis
3.10 PESTEL analysis
Chapter 4 Immunohematology Market, By Product
4.1 Key segment trends
4.2 Analyzers
4.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.3 Reagents
4.3.1 Market size, by region, 2016 – 2027 (USD Million)
Chapter 5 Immunohematology Market, By Technology
5.1 Key segment trends
5.2 Biochips
5.2.1 Market size, by region, 2016 – 2027 (USD Million)
5.3 Gel Cards
5.3.1 Market size, by region, 2016 – 2027 (USD Million)
5.4 Microplates
5.4.1 Market size, by region, 2016 – 2027 (USD Million)
5.5 PCR
5.5.1 Market size, by region, 2016 – 2027 (USD Million)
5.6 Erythrocyte-Magnetized Technology
5.6.1 Market size, by region, 2016 – 2027 (USD Million)
5.7 Others
5.7.1 Market size, by region, 2016 – 2027 (USD Million)
Chapter 6 Immunohematology Market, By End-use
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market size, 2016 - 2027 (USD Million)
6.3 Diagnostic Laboratories
6.3.1 Market size, 2016 - 2027 (USD Million)
6.4 Blood banks
6.4.1 Market size, 2016 - 2027 (USD Million)
6.5 Blood banks
6.5.1 Market size, 2016 - 2027 (USD Million)
Chapter 7 Immunohematology Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2016 - 2027 (USD Million)
7.2.2 Market size, by product, 2016 - 2027 (USD Million)
7.2.3 Market size, by technology, 2016 - 2027 (USD Million)
7.2.4 Market size, by end-use, 2016 - 2027 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by product, 2016 - 2027 (USD Million)
7.2.5.2 Market size, by technology, 2016 - 2027 (USD Million)
7.2.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by product, 2016 - 2027 (USD Million)
7.2.6.2 Market size, by technology, 2016 - 2027 (USD Million)
7.2.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2016 - 2027 (USD Million)
7.3.2 Market size, by product, 2016 - 2027 (USD Million)
7.3.3 Market size, by technology, 2016 - 2027 (USD Million)
7.3.4 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by product, 2016 - 2027 (USD Million)
7.3.5.2 Market size, by technology, 2016 - 2027 (USD Million)
7.3.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by product, 2016 - 2027 (USD Million)
7.3.6.2 Market size, by technology, 2016 - 2027 (USD Million)
7.3.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.7 France
7.3.7.1 Market size, by product, 2016 - 2027 (USD Million)
7.3.7.2 Market size, by technology, 2016 - 2027 (USD Million)
7.3.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.8 Spain
7.3.8.1 Market size, by product, 2016 - 2027 (USD Million)
7.3.8.2 Market size, by technology, 2016 - 2027 (USD Million)
7.3.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.9 Italy
7.3.9.1 Market size, by product, 2016 - 2027 (USD Million)
7.3.9.2 Market size, by technology, 2016 - 2027 (USD Million)
7.3.9.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.10 Russia
7.3.10.1 Market size, by product, 2016 - 2027 (USD Million)
7.3.10.2 Market size, by technology, 2016 - 2027 (USD Million)
7.3.10.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.11 Poland
7.3.11.1 Market size, by product, 2016 - 2027 (USD Million)
7.3.11.2 Market size, by technology, 2016 - 2027 (USD Million)
7.3.11.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.12 Czech Republic
7.3.12.1 Market size, by product, 2016 - 2027 (USD Million)
7.3.12.2 Market size, by technology, 2016 - 2027 (USD Million)
7.3.12.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.3.13 Hungary
7.3.13.1 Market size, by product, 2016 - 2027 (USD Million)
7.3.13.2 Market size, by technology, 2016 - 2027 (USD Million)
7.3.13.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2016 - 2027 (USD Million)
7.4.2 Market size, by product, 2016 - 2027 (USD Million)
7.4.3 Market size, by technology, 2016 - 2027 (USD Million)
7.4.4 Market size, by end-use, 2016 - 2027 (USD Million)
7.4.5 Japan
7.4.5.1 Market size, by product, 2016 - 2027 (USD Million)
7.4.5.2 Market size, by technology, 2016 - 2027 (USD Million)
7.4.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.4.6 China
7.4.6.1 Market size, by product, 2016 - 2027 (USD Million)
7.4.6.2 Market size, by technology, 2016 - 2027 (USD Million)
7.4.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.4.7 India
7.4.7.1 Market size, by product, 2016 - 2027 (USD Million)
7.4.7.2 Market size, by technology, 2016 - 2027 (USD Million)
7.4.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.4.8 Australia
7.4.8.1 Market size, by product, 2016 - 2027 (USD Million)
7.4.8.2 Market size, by technology, 2016 - 2027 (USD Million)
7.4.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2016 - 2027 (USD Million)
7.5.2 Market size, by product, 2016 - 2027 (USD Million)
7.5.3 Market size, by technology, 2016 - 2027 (USD Million)
7.5.4 Market size, by end-use, 2016 - 2027 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by product, 2016 - 2027 (USD Million)
7.5.5.2 Market size, by technology, 2016 - 2027 (USD Million)
7.5.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by product, 2016 - 2027 (USD Million)
7.5.6.2 Market size, by technology, 2016 - 2027 (USD Million)
7.5.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
7.6 Middle East & Africa
7.6.1 Market size, by country, 2016 - 2027 (USD Million)
7.6.2 Market size, by product, 2016 - 2027 (USD Million)
7.6.3 Market size, by technology, 2016 - 2027 (USD Million)
7.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by product, 2016 - 2027 (USD Million)
7.6.5.2 Market size, by technology, 2016 - 2027 (USD Million)
7.6.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard
8.2 Thermo Fisher Scientific
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Beckman Coulter
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 Hologic
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Siemens Healthcare GmbH
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Grifols
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 Ortho Clinical Diagnostics
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Immucor
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 BD (Becton Dickinson)
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 Abbott
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 MTC Invitro
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
8.12 Antisel
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 Strategic outlook
8.12.5 SWOT analysis
8.13 Roche Diagnostics
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 Strategic outlook
8.13.5 SWOT analysis
8.14 Bio-Rad Laboratories
8.14.1 Business overview
8.14.2 Financial data
8.14.3 Product landscape
8.14.4 Strategic outlook
8.14.5 SWOT analysis
